AzTrials
AzTrials

Postpartum DepressionMaMaNCT06049433

Maternal Mental Health Access - MaMa

A study testing Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention, On-Demand + Discussion board (DB) and Arm 2 in people with Postpartum Depression and Perinatal Depression, run by University of Utah at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This hybrid effectiveness-implementation project will allow the team to evaluate and refine implementation in preparation for future multisite trials to ultimately move the Evidence-Based Intervention (EBI) to scale among diverse populations. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Postpartum Depression, Perinatal Depression
What is being tested?
Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention, On-Demand + Discussion board (DB) and Arm 2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
4 Apr 2023to 30 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18+ years of age, who at the time of screening
  • Have a viable pregnancy or are postpartum (up to 1 year)
  • Identified as at-risk for PD (any one of the following:
  • EPDS score equal to or greater than 9 or less than 21
  • History of depression/anxiety
  • 2 or more significant life events)
  • English- or Spanish-speaking
  • Currently attending a UHealth clinic or rural public health partner clinic.

Who cannot join

  • Have a substance use disorder
  • Current diagnosis of serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression (including EPDS > 20)
  • Severe anxiety, suicidality, or currently taking any medications for a mental health condition.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gwen Latendresse, PhD CNM contact

(801) 587-9636

gwen.latendresse@nurs.utah.edu

United States1 site, 1 recruiting
  • University of Utah

    Salt Lake City, Utah, 84132

    Gwen Latendresse, PhD CNM, 801-587-9636, gwen.latendresse@nurs.utah.edu

    Julie Neuberger, BS, 801-587-3930, julie.neuberger@nurs.utah.edu

    Recruiting

Other trials in United States

About this study

Official title: Prevention of Perinatal Depression Among At-risk Individuals Through Integration of a Multimedia, Web-based Intervention Within the Healthcare System

This hybrid effectiveness-implementation project will allow the team to evaluate and refine implementation in preparation for future multisite trials to ultimately move the Evidence-Based Intervention (EBI) to scale among diverse populations. The plan is to enroll 120 at-risk pregnant and postpartum women from rural, urban, and Latino populations. Using a randomized preference design to also evaluate patient and sociocultural factors in participation and symptom trajectory.

Using the Implementation Research Logic Model, the team will evaluate the implementation feasibility and acceptability of a remote-access and on-demand MBCT PD prevention intervention that is integrated within maternal clinical care settings using an existing patient portal. Successful achievement of the study aims will result in a refined implementation protocol for future studies that are sufficiently powered to evaluate the effectiveness of an integrated Digital Mental Health Technology and to estimate the cost/benefit ratio

Read the detailed description

This type1 hybrid effectiveness-implementation project is conducted within healthcare settings and underserved populations (rural, urban, and Latino) and for individuals who are at risk for perinatal depression (PD), which allows the team to refine the approach in preparation for a future effectiveness trial for the prevention of PD in diverse communities using accessible Digital Mental Health Technology (patient education portal, FB discussion boards, synchronous videoconference support sessions). The plan is to adopt a randomized preference trial design to assess the impact of patient preference and sociocultural factors (including race, ethnicity, and geographic residence) on engagement and preliminary results. This information is crucial for a subsequent trial and for ultimately taking the intervention to scale. The study design using the IRLM reflects scientific rigor that can be reproduced by other investigators. The implemented strategies specifically developed to optimize implementation success, and to measure the implementation outcomes of these strategies and include valuable input from key informants, stakeholders, and the Community Advisory Board at regular intervals throughout the project time period.

Being tested
Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention, On-Demand + Discussion board (DB), Arm 2, On Demand (OD) + Video Conference (VC), Arm 3
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- interventionBehavioural

    Also called Arm 1, On-Demand (OD)

    The intervention uses a standardized, manualized program (UPLIFT - Using Practice and Learning to Increase Favorable Thoughts) based on Mindfulness-Based Cognitive Behavioral Therapy (MBCT) in the prevention of depression in various populations and settings. MBCT can be delivered individually and in groups and via electronic platforms, in diverse populations. We have adapted UPLIFT for this study, based on input from focus groups and in response to the ongoing pandemic, and under the direction of our team's mental health professionals. Adaptations include access to asynchronous, on-demand multi-media MBCT content (digital audio-video files and downloadable content),

  • On-Demand + Discussion board (DB)Behavioural

    Adaptations include access to asynchronous, on-demand multi-media MBCT content (digital audio-video files and downloadable content), as well as synchronous Videoconference (VC) reduced from 8 weekly one-hour sessions to 4 one-hour sessions every two weeks. a discussion board with the potential to build a sense of community in a similar way that synchronous VC groups provide.

  • Arm 2Behavioural

    Also called On-Demand (OD) + Discussion Board (DB)

    The intervention uses a standardized, manualized program (UPLIFT - Using Practice and Learning to Increase Favorable Thoughts) based on Mindfulness-Based Cognitive Behavioral Therapy (MBCT) in the prevention of depression in various populations and settings. MBCT can be delivered individually and in groups and via electronic platforms, in diverse populations. On-demand multi-media MBCT content (digital audio-video files and downloadable content)

  • On Demand (OD) + Video Conference (VC)Behavioural

    on-demand multi-media MBCT content (digital audio-video files and downloadable content), as well as synchronous Videoconference (VC) reduced from 8 weekly one-hour sessions to 4 one-hour sessions every two weeks. A discussion board with the potential to build a sense of community in a similar way that synchronous VC groups provide.

  • Arm 3Behavioural

    Also called On Demand (OD)

    The intervention uses a standardized, manualized program (UPLIFT - Using Practice and Learning to Increase Favorable Thoughts) based on Mindfulness-Based Cognitive Behavioral Therapy (MBCT) in the prevention of depression in various populations and settings.

  • On Demand (OD) + Video Conference (VC)Behavioural

    Access to asynchronous, on-demand multi-media MBCT content (digital audio-video files and downloadable content), as well as synchronous Videoconference (VC)

Study groups in NCT06049433
Study groupRoleWhat they receive
Choice 1OtherOptions; On-Demand (OD) alone or On-Demand (OD) with a facilitated discussion board (DB)
Receives: Behavioral: Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention; Behavioral: On-Demand + Discussion board (DB)
Choice 2OtherOptions: On-Demand (OD) + Discussion board (DB) or OD + Video Conference (VC)
Receives: Behavioral: Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention; Behavioral: Arm 2; Behavioral: On Demand (OD) + Video Conference (VC)
Choice 3OtherOptions; Om-Demand (OD) or On-Demand (OD) + Video Conference (VC)
Receives: Behavioral: Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention; Behavioral: Arm 3; Behavioral: On Demand (OD) + Video Conference (VC)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implementation outcome; Feasibility and acceptability

    EPDS Scores are between 0 and 30, with scores 13 and above indicating depressive illness, or a high risk of developing a depressive disorder. Using scores that are between 9-20 Qualitative; semi structured interview Quantitative; patient satisfaction survey, number of referrals for at-risk patients, patients registering on YoMingo. focus groups, individual interviews, questionnaires

    Measured: (6, 12 & 18 months)

Secondary outcomes (1)
  1. Sociocultural Determinants and Behavior

    EPDS Scores are between 0 and 30, with scores 13 and above indicating depressive illness, or a high risk of developing a depressive disorder.- using EPDS score between 9-20. Life events, cultural/ethnical/racial group membership, history of depression, mental stigma

    Measured: 6, 12 & 18 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2023
  2. Study start4 Apr 2023
  3. Primary completion30 Aug 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06049433
Sponsor's protocol ID
00159109
Other IDs
RF1NR020841
Acronym
MaMa
Status last verified
Dec 2024
First submitted
23 Aug 2023
Last updated
6 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention, On-Demand + Discussion board (DB) and Arm 2 in people with Postpartum Depression and Perinatal Depression, run by University of Utah at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gwen Latendresse, PhD CNM ((801) 587-9636, gwen.latendresse@nurs.utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implementation outcome; Feasibility and acceptability (time frame: (6, 12 & 18 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in